Betterlife Pharma Stock Analysis

BETRF Stock  USD 0.08  0.01  9.59%   
BetterLife Pharma is overvalued with Real Value of 0.0689 and Hype Value of 0.08. The main objective of BetterLife Pharma otc analysis is to determine its intrinsic value, which is an estimate of what BetterLife Pharma is worth, separate from its market price. There are two main types of BetterLife Pharma's stock analysis: fundamental analysis and technical analysis.
The BetterLife Pharma otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and BetterLife Pharma's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BetterLife Pharma. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

BetterLife OTC Stock Analysis Notes

The company recorded a loss per share of 0.12. BetterLife Pharma last dividend was issued on the 26th of June 2020. The entity had 1:10 split on the 26th of June 2020. BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada. Betterlife Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for BetterLife Pharma is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on BetterLife Pharma please contact Ahmad Doroudian at 778 997 1928 or go to https://www.abetterlifepharma.com.

BetterLife Pharma Investment Alerts

BetterLife Pharma had very high historical volatility over the last 90 days
BetterLife Pharma has some characteristics of a very speculative penny stock
BetterLife Pharma has high likelihood to experience some financial distress in the next 2 years
BetterLife Pharma has accumulated 34.56 K in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. BetterLife Pharma has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BetterLife Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, BetterLife Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BetterLife Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BetterLife to invest in growth at high rates of return. When we think about BetterLife Pharma's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (12.16 M) with loss before overhead, payroll, taxes, and interest of (22.81 K).
BetterLife Pharma has accumulated about 14.41 K in cash with (11.2 M) of positive cash flow from operations.

BetterLife Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BetterLife Pharma's market, we take the total number of its shares issued and multiply it by BetterLife Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 16th of December 2024, BetterLife Pharma shows the Mean Deviation of 5.93, risk adjusted performance of 0.0102, and Downside Deviation of 9.31. BetterLife Pharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for BetterLife Pharma, which can be compared to its peers. Please confirm BetterLife Pharma variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if BetterLife Pharma is priced correctly, providing market reflects its regular price of 0.08 per share. As BetterLife Pharma appears to be a penny stock we also recommend to validate its total risk alpha numbers.

BetterLife Pharma Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BetterLife Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BetterLife Pharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

BetterLife Pharma Outstanding Bonds

BetterLife Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BetterLife Pharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BetterLife bonds can be classified according to their maturity, which is the date when BetterLife Pharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

BetterLife Pharma Predictive Daily Indicators

BetterLife Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BetterLife Pharma otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

BetterLife Pharma Forecast Models

BetterLife Pharma's time-series forecasting models are one of many BetterLife Pharma's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BetterLife Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About BetterLife OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how BetterLife Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BetterLife shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as BetterLife Pharma. By using and applying BetterLife OTC Stock analysis, traders can create a robust methodology for identifying BetterLife entry and exit points for their positions.
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada. Betterlife Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding BetterLife Pharma to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Complementary Tools for BetterLife OTC Stock analysis

When running BetterLife Pharma's price analysis, check to measure BetterLife Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BetterLife Pharma is operating at the current time. Most of BetterLife Pharma's value examination focuses on studying past and present price action to predict the probability of BetterLife Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BetterLife Pharma's price. Additionally, you may evaluate how the addition of BetterLife Pharma to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Content Syndication
Quickly integrate customizable finance content to your own investment portal